CPC-111 fructose-1 data

CYPR announced positive results from its double-blind Phase II trial of CPC-111 to reduce pain associated with sickle cell anemia

Read the full 200 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE